摘要:
The present invention is directed to pharmaceutical formulations and tablet compositions of pharmacological active agents of Formula I that are estrogen receptor modulators, and preparative processes thereof.
摘要:
The present invention is directed to pharmaceutical formulations of an anhydrous crystal form of an estrogen receptor modulator, and pharmaceutical compositions and preparative processes thereof.
摘要:
The present invention is directed to pharmaceutical formulations of a monohydrate crystal form of an estrogen receptor modulator, and pharmaceutical compositions and preparative processes thereof.
摘要:
The present invention is directed to liquid or semi-solid pharmaceutical formulations of pharmacologically active agents of Formula I that are estrogen receptor modulators, and pharmaceutical compositions and preparative processes thereof.
摘要:
The present invention is directed to pharmaceutical formulations of a crystal form of an estrogen receptor modulator, and pharmaceutical compositions and preparative processes thereof.